FDA OKs ' Game-Changer ' Oral GLP-1 Agonist for Type 2 Diabetes FDA OKs ' Game-Changer ' Oral GLP-1 Agonist for Type 2 Diabetes

Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news